In reply to the letter to the editor 'in Reply to Gandaglia et al.' by De Bari et al.

Gandaglia, G; Karakiewicz, P I; Briganti, A; Menon, M; Sun, M; Abdollah, F

Gandaglia, G; Karakiewicz, P I; Briganti, A; Menon, M; Sun, M; Abdollah, F.

Afiliación

Gandaglia G; Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Canada; Division of Oncology/Unit of Urology, URI, IRCCS Ospedale San Raffaele, Milan, Italy.
Karakiewicz PI; Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Canada.
Briganti A; Division of Oncology/Unit of Urology, URI, IRCCS Ospedale San Raffaele, Milan, Italy.
Menon M; Vattikuti Urology Institute and VUI Center for Outcomes Research Analytics and Evaluation, Detroit, USA.
Sun M; Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Canada.
Abdollah F; Vattikuti Urology Institute and VUI Center for Outcomes Research Analytics and Evaluation, Detroit, USA. Electronic address: firas.abdollah@gmail.com.

Ann Oncol ; 25(9): 1862-1863, 2014 Sep.

Article en En | MEDLINE | ID: mdl-24914042

Asunto(s)

Neoplasias de la Próstata/radioterapia; Humanos; Masculino

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Próstata Límite: Humans / Male Idioma: En Revista: Ann Oncol Asunto de la revista: NEOPLASIAS Año: 2014 Tipo del documento: Article País de afiliación: Italia Pais de publicación: Reino Unido

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google